Find uplifting stories about heroes, innovations, and solutions
16244 results for "lung cancer research"
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
Over 1,000 survivors, families, and advocates turned a 1-mile zoo walk into a powerful statement of hope, crushing their fundraising goal. The event brought together a community that proves no one has to fight lung cancer alone.
Researchers in Hong Kong have developed the first drug that targets a specific cancer "switch" in lung cancer cells, shrinking tumors in lab tests without harming healthy tissue. The breakthrough could transform treatment for millions of people with the world's deadliest cancer.
A promising new pill shrank tumors in nearly two-thirds of lung cancer patients and 40% of pancreatic cancer patients in early trials. The results exceeded expectations and could offer fresh hope for people facing these difficult diagnoses.
Researchers discovered why some lung cancer cells resist treatment and found a natural compound that could help. The breakthrough reveals a "bodyguard system" that protects cancer cells and a way to shut it down.
Multiple research teams discovered that aggressive lung cancer cells form actual connections with brain neurons, and drugs that block these connections slow tumor growth in mice. The breakthrough could lead to new treatment options for one of the deadliest cancers.
A groundbreaking therapy is showing real promise against cancers long considered impossible to treat, shrinking tumors in patients who'd run out of options. The experimental drug targets a genetic mutation affecting thousands of lung and pancreatic cancer patients each year.
Researchers discovered a protein that helps lung cancer cells survive chemotherapy, opening the door to smarter treatments that could prevent deadly relapses. The breakthrough gives hope to patients facing one of cancer's toughest challenges.
UCLA researchers discovered a targeted therapy drug that dramatically reduces the risk of lung cancer returning in patients with a rare genetic subtype. After two years, 92% of patients receiving the treatment remained cancer-free, compared to just 61% who received a placebo.
A leukemia survivor and a researcher who beat cancer are driving groundbreaking pediatric cancer research at Purdue University, inspired by beloved student Tyler Trent. Their work focuses on making treatments safer and more effective for kids fighting cancer.
Researchers at Oregon State University developed a new therapy that fights lung cancer tumors while preventing deadly muscle wasting in a single treatment. Early results in mice show the approach works 2.5 times better than standard treatments without harmful side effects.
Researchers are unlocking new ways to detect and treat lung cancer in people who've never smoked, a distinct form of the disease that's often caught too late. Countries like Taiwan are already testing screening programs for at-risk non-smokers, offering hope for earlier detection.
A new pill targeting aggressive pancreatic and lung cancers showed remarkable results in early trials, shrinking tumors in nearly two-thirds of lung cancer patients. The therapy offers fresh hope for patients facing some of the deadliest cancer diagnoses.
Researchers in Sweden discovered why lung cancer spreads faster in older patients and found a promising way to stop it. The breakthrough could lead to more effective, personalized treatments for the patients who need them most.
A groundbreaking cancer treatment just showed remarkable results that exceeded doctors' expectations in treating one of the deadliest forms of lung cancer. The drug ivonescimab reduced the risk of death by 34% compared to standard treatment for patients with squamous non-small cell lung cancer.
Scientists at the University of Colorado have discovered how to eliminate cancer cells that survive initial treatment, potentially turning lung cancer into a curable disease. The breakthrough combines two therapies to attack cancer at its most vulnerable moment.
Berlin researchers can now grow tiny replicas of a patient's lung tumor to test which treatments will work best before starting therapy. This breakthrough could help doctors choose the most effective cancer treatment for each individual patient.
Researchers analyzed real-world data from 940 patients to compare five lung cancer drugs, finding clearer answers about which treatments work best. The findings could help doctors and patients make smarter decisions about care.
A promising new lung cancer treatment called Pumitamig is giving hope to patients with advanced disease, showing a 70% response rate regardless of their PD-L1 status. The breakthrough was announced at the 2026 ASCO conference, one of the world's leading cancer research gatherings.
Cancer survivors rang bells and shared stories as Marco Island's Imagination Ball combined timeless elegance with lifesaving purpose. The American Cancer Society fundraiser brought the community together to support research that could one day end cancer diagnoses.
Showing 20 of 16244